Literature DB >> 25954450

A method for analyzing commonalities in clinical trial target populations.

Zhe He1, Simona Carini2, Tianyong Hao1, Ida Sim2, Chunhua Weng1.   

Abstract

ClinicalTrials.gov presents great opportunities for analyzing commonalities in clinical trial target populations to facilitate knowledge reuse when designing eligibility criteria of future trials or to reveal potential systematic biases in selecting population subgroups for clinical research. Towards this goal, this paper presents a novel data resource for enabling such analyses. Our method includes two parts: (1) parsing and indexing eligibility criteria text; and (2) mining common eligibility features and attributes of common numeric features (e.g., A1c). We designed and built a database called "Commonalities in Target Populations of Clinical Trials" (COMPACT), which stores structured eligibility criteria and trial metadata in a readily computable format. We illustrate its use in an example analytic module called CONECT using COMPACT as the backend. Type 2 diabetes is used as an example to analyze commonalities in the target populations of 4,493 clinical trials on this disease.

Entities:  

Mesh:

Year:  2014        PMID: 25954450      PMCID: PMC4419878     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  13 in total

1.  The Unified Medical Language System (UMLS): integrating biomedical terminology.

Authors:  Olivier Bodenreider
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

3.  A method for probing disease relatedness using common clinical eligibility criteria.

Authors:  Mary Regina Boland; Riccardo Miotto; Chunhua Weng
Journal:  Stud Health Technol Inform       Date:  2013

4.  Unsupervised mining of frequent tags for clinical eligibility text indexing.

Authors:  Riccardo Miotto; Chunhua Weng
Journal:  J Biomed Inform       Date:  2013-09-10       Impact factor: 6.317

5.  A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.

Authors:  C Weng; Y Li; P Ryan; Y Zhang; F Liu; J Gao; J T Bigger; G Hripcsak
Journal:  Appl Clin Inform       Date:  2014-05-07       Impact factor: 2.342

6.  A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group.

Authors:  A Fuks; C Weijer; B Freedman; S Shapiro; M Skrutkowska; A Riaz
Journal:  J Clin Epidemiol       Date:  1998-02       Impact factor: 6.437

7.  A human-computer collaborative approach to identifying common data elements in clinical trial eligibility criteria.

Authors:  Zhihui Luo; Riccardo Miotto; Chunhua Weng
Journal:  J Biomed Inform       Date:  2012-07-27       Impact factor: 6.317

8.  Clustering clinical trials with similar eligibility criteria features.

Authors:  Tianyong Hao; Alexander Rusanov; Mary Regina Boland; Chunhua Weng
Journal:  J Biomed Inform       Date:  2014-02-01       Impact factor: 6.317

9.  Analysis of eligibility criteria complexity in clinical trials.

Authors:  Jessica Ross; Samson Tu; Simona Carini; Ida Sim
Journal:  Summit Transl Bioinform       Date:  2010-03-01

10.  Use of hangeul twitter to track and predict human influenza infection.

Authors:  Eui-Ki Kim; Jong Hyeon Seok; Jang Seok Oh; Hyong Woo Lee; Kyung Hyun Kim
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more
  14 in total

1.  Assessing the population representativeness of colorectal cancer treatment clinical trials.

Authors:  Thomas J George; Gloria Lipori
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2016-08

2.  Comparing and Contrasting A Priori and A Posteriori Generalizability Assessment of Clinical Trials on Type 2 Diabetes Mellitus.

Authors:  Zhe He; Arturo Gonzalez-Izquierdo; Spiros Denaxas; Andrei Sura; Yi Guo; William R Hogan; Elizabeth Shenkman; Jiang Bian
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

3.  Visual aggregate analysis of eligibility features of clinical trials.

Authors:  Zhe He; Simona Carini; Ida Sim; Chunhua Weng
Journal:  J Biomed Inform       Date:  2015-01-20       Impact factor: 6.317

4.  Simulation-based Evaluation of the Generalizability Index for Study Traits.

Authors:  Zhe He; Praveen Chandar; Patrick Ryan; Chunhua Weng
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

5.  Analysis of Temporal Constraints in Qualitative Eligibility Criteria of Cancer Clinical Studies.

Authors:  Zhe He; Zhiwei Chen; Jiang Bian
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2017-01-19

Review 6.  Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review.

Authors:  Kory Kreimeyer; Matthew Foster; Abhishek Pandey; Nina Arya; Gwendolyn Halford; Sandra F Jones; Richard Forshee; Mark Walderhaug; Taxiarchis Botsis
Journal:  J Biomed Inform       Date:  2017-07-17       Impact factor: 6.317

7.  Assessing the Collective Population Representativeness of Related Type 2 Diabetes Trials by Combining Public Data from ClinicalTrials.gov and NHANES.

Authors:  Zhe He; Shuang Wang; Elhaam Borhanian; Chunhua Weng
Journal:  Stud Health Technol Inform       Date:  2015

8.  Multivariate analysis of the population representativeness of related clinical studies.

Authors:  Zhe He; Patrick Ryan; Julia Hoxha; Shuang Wang; Simona Carini; Ida Sim; Chunhua Weng
Journal:  J Biomed Inform       Date:  2016-01-25       Impact factor: 6.317

9.  A knowledge base of clinical trial eligibility criteria.

Authors:  Hao Liu; Yuan Chi; Alex Butler; Yingcheng Sun; Chunhua Weng
Journal:  J Biomed Inform       Date:  2021-04-01       Impact factor: 6.317

10.  Automated classification of clinical trial eligibility criteria text based on ensemble learning and metric learning.

Authors:  Kun Zeng; Yibin Xu; Ge Lin; Likeng Liang; Tianyong Hao
Journal:  BMC Med Inform Decis Mak       Date:  2021-07-30       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.